These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 37298365)

  • 21. [Clinical aspects and therapy of toxic hepatitis].
    Colić-Cvrlje V; Naumovski-Mihalić S; Colić A
    Acta Med Croatica; 2003; 57(3):183-8. PubMed ID: 14582464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.
    den Brinker M; Wit FW; Wertheim-van Dillen PM; Jurriaans S; Weel J; van Leeuwen R; Pakker NG; Reiss P; Danner SA; Weverling GJ; Lange JM
    AIDS; 2000 Dec; 14(18):2895-902. PubMed ID: 11153671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients.
    Labarga P; Soriano V; Vispo ME; Pinilla J; Martin-Carbonero L; Castellares C; Casado R; Maida I; Garcia-Gasco P; Barreiro P
    J Infect Dis; 2007 Sep; 196(5):670-6. PubMed ID: 17674307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury.
    Cho YE; Im EJ; Moon PG; Mezey E; Song BJ; Baek MC
    PLoS One; 2017; 12(2):e0172463. PubMed ID: 28225807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced hepatotoxicity in cancer patients - implication for treatment.
    Vincenzi B; Armento G; Spalato Ceruso M; Catania G; Leakos M; Santini D; Minotti G; Tonini G
    Expert Opin Drug Saf; 2016 Sep; 15(9):1219-38. PubMed ID: 27232067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
    Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
    BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication.
    Choi SS; Claridge LC; Jhaveri R; Swiderska-Syn M; Clark P; Suzuki A; Pereira TA; Mi Z; Kuo PC; Guy CD; Pereira FE; Diehl AM; Patel K; Syn WK
    Clin Sci (Lond); 2014 Jun; 126(12):845-55. PubMed ID: 24438228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
    Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
    Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
    Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
    BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.
    Iqbal J; McRae S; Banaudha K; Mai T; Waris G
    J Biol Chem; 2013 Dec; 288(52):36994-7009. PubMed ID: 24240095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.
    Antoine DJ; Jenkins RE; Dear JW; Williams DP; McGill MR; Sharpe MR; Craig DG; Simpson KJ; Jaeschke H; Park BK
    J Hepatol; 2012 May; 56(5):1070-1079. PubMed ID: 22266604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of alpha-glutathione S-transferase as a sensitive marker of increased risk for hepatocellular damage in hepatitis C virus (HCV) infection: relation to HCV viraemia.
    Helaly GF; Mahmoud MM
    J Egypt Public Health Assoc; 2003; 78(3-4):209-23. PubMed ID: 17265614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection.
    Bliven EE; Podewils LJ
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1054-60. PubMed ID: 19723392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients.
    Stone SF; Lee S; Keane NM; Price P; French MA
    J Infect Dis; 2002 Nov; 186(10):1498-502. PubMed ID: 12404169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy.
    Kwon YS; Koh WJ; Suh GY; Chung MP; Kim H; Kwon OJ
    Chest; 2007 Mar; 131(3):803-808. PubMed ID: 17356096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44.
    Iqbal J; Sarkar-Dutta M; McRae S; Ramachandran A; Kumar B; Waris G
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients.
    McGill MR; Jaeschke H
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):1005-17. PubMed ID: 24836926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.
    Van Welzen B; Mudrikova T; Arends J; Hoepelman A
    HIV Med; 2012 Aug; 13(7):448-52. PubMed ID: 22413955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.